Akèy › Twoub Defisi Atansyon ak Ipèaktivite
Etid klinik pou Twoub Defisi Atansyon ak Ipèaktivite ap rekrite nan Etazini
68 etid pou Twoub Defisi Atansyon ak Ipèaktivite ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA10 etid
- Cincinnati, OH8 etid
- Austin, TX6 etid
- Philadelphia, PA6 etid
- Washington, DC5 etid
- Orlando, FL5 etid
- Las Vegas, NV5 etid
- Pittsburgh, PA5 etid
- Memphis, TN4 etid
- New York City, NY4 etid
- Jacksonville, FL4 etid
- Jackson, MS4 etid
- Durham, NC4 etid
- Atlanta, GA4 etid
- Baltimore, MD4 etid
- Los Angeles, CA4 etid
- Irvine, CA4 etid
- Houston, TX3 etid
- Portland, OR3 etid
- Gainesville, FL3 etid
- Kendall, FL3 etid
- North Charleston, SC3 etid
- Harrisburg, PA3 etid
- Little Rock, AR3 etid
- Long Beach, CA3 etid
- Mountain View, CA3 etid
- Sacramento, CA3 etid
- Seattle, WA3 etid
Pa eta
- Alabama4 etid
- Arkansas4 etid
- Florid7 etid
- Georgia4 etid
- Kalifòni15 etid
- Kentucky3 etid
- Lwizyàn3 etid
- Maryland7 etid
- Massachusetts12 etid
- Michigan3 etid
- Mississippi4 etid
- Nevada5 etid
- New Jersey3 etid
- New York7 etid
- North Carolina5 etid
- Ohio9 etid
- Oregon4 etid
- Pennsylvania12 etid
- South Carolina5 etid
- Tennessee4 etid
- Texas8 etid
- Utah3 etid
- Virginia3 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Role of Theta Frequency Oscillations in Proactive and Reactive Control Processes in Youth With Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 10 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT07566468Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
Ap rekriteFaz 1/2
Laj 8 a 16 · Tout sèks · Mizajou Sep 30, 2026 · NCT05608434Developing Brain, Impulsivity and Compulsivity
Ap rekriteEtid obsèvasyon
Laj 6 a 80 · Tout sèks · Mizajou Sep 25, 2026 · NCT04631042Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder
Ap rekrite
Laj 18 a 55 · Tout sèks · Mizajou Sep 21, 2026 · NCT07793045Fidgeting and Attentional and Emotional Regulation in ADHD
Ap rekrite
Laj 18 a 30 · Tout sèks · Mizajou Sep 15, 2026 · NCT04526600A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07759154Treating Young Children With Attention Deficit Hyperactivity Disorder
Ap rekriteFaz 4
Laj 3 a 5 · Tout sèks · Mizajou Sep 14, 2026 · NCT07300956Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Ap rekriteFaz 4
48 Months – 69 Months · Tout sèks · Mizajou Sep 11, 2026 · NCT04781140Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Ap rekriteFaz 1
Laj 8 a 17 · Tout sèks · Mizajou Sep 9, 2026 · NCT07226219Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717892Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717879MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Fanm · Mizajou Sep 8, 2026 · NCT07540585Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD
Ap rekrite
Laj 4 a 8 · Tout sèks · Mizajou Aug 25, 2026 · NCT07784348Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 a 20 · Tout sèks · Mizajou Aug 21, 2026 · NCT04278404Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Aug 19, 2026 · NCT05776056Smartphone-based Intervention for Young Adults With ADHD
Ap rekrite
Laj 18 a 25 · Tout sèks · Mizajou Aug 18, 2026 · NCT07654205Impact of Short and Mistimed Sleep on Adolescents With ADHD: The Adolescent Attention and Circadian Timing Study
Ap rekrite
Laj 13 a 17 · Tout sèks · Mizajou Aug 17, 2026 · NCT07684417A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Aug 10, 2026 · NCT07755410Virtual Reality Attention Management
Ap rekrite
Laj 8 a 12 · Tout sèks · Mizajou Aug 7, 2026 · NCT03221244Medication Treatment of ADHD in Pediatric Epilepsy
Ap rekriteFaz 4
Laj 6 a 17 · Tout sèks · Mizajou Jul 29, 2026 · NCT07594652Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
Ap rekrite
Laj 8 a 12 · Tout sèks · Mizajou Jul 16, 2026 · NCT06847165Atomoxetine and Executive Function in PTSD
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Jul 7, 2026 · NCT06573970Enhancing Team Effectiveness for a Collaborative School-based Intervention for ADHD
Ap rekrite
Laj 7 a 11 · Tout sèks · Mizajou Jun 30, 2026 · NCT06180681Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT05802680Effects of Transcranial Photobiomodulation in ADHD
Ap rekrite
Laj 18 a 44 · Tout sèks · Mizajou Jun 22, 2026 · NCT07203092Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.